The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy ...
15h
Zacks Investment Research on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...
15h
Zacks Investment Research on MSNBEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA ClearanceBeam Therapeutics Inc. BEAM announced that the FDA has cleared the investigational new drug (IND) application to begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results